SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-030353
Filing Date
2024-02-09
Accepted
2024-02-09 17:24:53
Documents
1
Group Members
BLACKSTONE CLARUS DE L.L.C.BLACKSTONE CLARUS GP L.L.C.BLACKSTONE CLARUS GP L.P.BLACKSTONE CLARUS III L.L.C.BLACKSTONE GROUP MANAGEMENT L.L.C.BLACKSTONE HOLDINGS I L.P.BLACKSTONE HOLDINGS I/II GP L.L.C.BLACKSTONE INC.CLARUS DE II, L.P.CLARUS DEFINED EXIT I

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d133130dsc13ga.htm SC 13G/A 306671
  Complete submission text file 0001193125-24-030353.txt   309124
Mailing Address C/O BLACKSTONE INC. 345 PARK AVENUE NEW YORK NY 10154
Business Address C/O BLACKSTONE INC. 345 PARK AVENUE NEW YORK NY 10154 212-583-5000
Blackstone Holdings II L.P. (Filed by) CIK: 0001484870 (see all company filings)

IRS No.: 260288604
Type: SC 13G/A

Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Subject) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92543 | Film No.: 24616266
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)